Cumulative incidence of and predictive factors for lung cancer in IPF

Y Ozawa, T Suda, T Naito, N Enomoto… - …, 2009 - Wiley Online Library
Background and objective: Previous studies have indicated a high incidence of lung cancer
in IPF, and some have identified its risk factors. However, those studies were retrospective …

[HTML][HTML] Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases

T Suda, Y Kaida, Y Nakamura, N Enomoto… - Respiratory …, 2009 - Elsevier
BACKGROUND: Acute exacerbation (AE) is currently established as a distinct condition
with acute deterioration of respiratory status in idiopathic pulmonary fibrosis (IPF). Recently, …

Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis.

T Fujisawa, T Suda, Y Nakamura, N Enomoto… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: To assess the difference in clinical features and prognosis of patients with
interstitial lung disease (ILD) comparing polymyositis (PM) and dermatomyositis (DM). METHODS…

[HTML][HTML] Prognostic factors for myositis-associated interstitial lung disease

T Fujisawa, H Hozumi, M Kono, N Enomoto… - PLoS one, 2014 - journals.plos.org
Background Interstitial lung disease (ILD) is a common manifestation of polymyositis (PM),
dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM); however, little is …

Interstitial lung diseases associated with amyopathic dermatomyositis

T Suda, T Fujisawa, N Enomoto… - European …, 2006 - Eur Respiratory Soc
The aim of the present study was to clarify the clinical characteristics and prognosis of
patients with interstitial lung disease (ILD) associated with amyopathic dermatomyositis (ILD-ADM)…

[HTML][HTML] Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease

…, T Johkoh, H Sumikawa, A Murakami, N Enomoto… - Respiratory …, 2016 - Elsevier
Objectives Myositis-specific autoantibodies (MSAs) are associated with clinical phenotypes
in polymyositis/dermatomyositis (PM/DM). No study has investigated the clinical features …

Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study

…, TV Colby, M Kono, D Hashimoto, N Enomoto… - BMJ open, 2013 - bmjopen.bmj.com
Objectives To investigate the risk factors and prognosis associated with acute exacerbation (AE)
in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). …

Mouse Lung CD103+ and CD11bhigh Dendritic Cells Preferentially Induce Distinct CD4+ T-Cell Responses

…, Y Suzuki, D Hashimoto, N Enomoto… - American journal of …, 2012 - atsjournals.org
Mouse lung dendritic cells (LDCs) have been recently shown to contain two major subpopulations:
CD103 + CD11b low or negative (CD103 + LDCs) and CD103 − CD11b high LDCs (…

[HTML][HTML] The multicenter study of a new assay for simultaneous detection of multiple anti-aminoacyl-tRNA synthetases in myositis and interstitial pneumonia

…, K Yamamoto, H Kohsaka, Y Takasaki, N Enomoto… - PloS one, 2014 - journals.plos.org
Objective Autoantibodies to aminoacyl-tRNA synthetases (ARSs) are useful in the diagnosis
of idiopathic inflammatory myopathy (IIM) with interstitial pneumonia (IP). We developed an …

[HTML][HTML] Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: a retrospective multicenter study

Y Enomoto, Y Nakamura, Y Satake, H Sumikawa… - Respiratory …, 2017 - Elsevier
Background Although the accurate diagnosis of pleuroparenchymal fibroelastosis (PPFE)
requires pathologic evaluation, this diagnosis is often suggested when the radiologic findings …